Key result
Angiotensin-receptor blockers have evolved from antihypertensives to demonstrate benefits in diabetes and heart failure, with ongoing trials exploring broader cardiovascular indications.
Why the study?
Do angiotensin-receptor blockers provide cardiovascular benefits beyond blood pressure reduction in patients with diabetes and heart failure?
Population
Patients with hypertension, diabetes, and heart failure
Design
Review
Authors
Loading...
May inform ARB selection in diabetes or heart failure; leaves broader CV indications open for prospective trials.
Do angiotensin-receptor blockers provide cardiovascular benefits beyond blood pressure reduction in patients with diabetes and heart failure?
Angiotensin-receptor blockers have expanded their role from antihypertensives to comprehensive cardiovascular medications with benefits in heart failure and diabetes.
Maggioni et al. (2002) conducted a review in Hypertension, diabetes, heart failure. Angiotensin-receptor blockers was evaluated. Angiotensin-receptor blockers have evolved from antihypertensives to demonstrate benefits in diabetes and heart failure, with ongoing trials exploring broader cardiovascular indications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: